3M Co

3M’s surge in institutional buying, a new Credo licensing deal, and a profit‑driven strategy suggest short‑term upside for income investors, but growth hopes may wane.

3M’s 2025 earnings hit growth, but a revised 2026 outlook tied to tariff and commodity risks drops shares—learn what drives the new strategy and risks.

3M’s Q4 2025 earnings, slated for Jan 20 2026, forecast an EPS of $1.80—up 35% from last year—showing how its diversified electronics, healthcare and safety portfolio can drive resilient growth amid global market shifts.

JPMorgan downgrades 3M’s outlook to neutral, citing market softness, competitive pressures and inflation‑driven limits on industrial demand—yet the conglomerate’s diversified portfolio and strong balance sheet still appeal to long‑term investors.

JP Morgan downgrades 3M to neutral with a $182 target, citing steady capex but muted upside amid market calm, ESG costs and supply‑chain pressures.

3M’s steady 2026 cap‑ex plan—$3.1B for IoT, sustainability, and a new abrasives plant—shows how its tech‑driven, ESG‑aligned strategy keeps the industrial conglomerate a reliable dividend‑yielding choice.

3M’s Q4 2025 earnings show modest profit growth, rising margins, and stable revenue from industrial and healthcare segments, underscoring its resilient, innovation‑driven strategy.

3M’s Q4 2025 earnings call: how industrial momentum fuels consumer trends, sustainability, and AI‑driven retail innovation for Millennials and Gen Z.

3M’s steady growth shows how industrial giants can thrive as Gen Z, sustainability and digital‑first shopping reshape consumer discretionary spending.

3M’s AI‑driven tools—Ask 3M and the Digital Materials Hub—reshape design workflows, boost customer engagement, and cut prototype costs, positioning the company as a digital material leader ahead of CES 2026.